Get the Stockscreener App
2.86
32.41%
0.70
After Hours:
2.80
-0.06
-2.10%
Vivopower Plc stock is traded at $2.86, with a volume of 3.40M.
It is up +32.41% in the last 24 hours and down -91.58% over the past month.
VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications. The group delivers specialized infrastructure solutions across the AI Data Centers, Power-to-X, and Electric Mobility. It is develop and operated infrastructure that enables sovereign nations and institutional partners to secure control over power, data, and national intelligence, supporting AI, compute-intensive workloads, and energy transition use cases.
See More
Previous Close:
$2.16
Open:
$2.4
24h Volume:
3.40M
Relative Volume:
28.87
Market Cap:
$48.02M
Revenue:
$5.95M
Net Income/Loss:
$-23.44M
P/E Ratio:
-0.4397
EPS:
-6.5047
Net Cash Flow:
$-2.39M
1W Performance:
+17.21%
1M Performance:
-91.58%
6M Performance:
-91.58%
1Y Performance:
-91.58%
1-Day Range:
$2.37
$3.08
1-Week Range:
$2.16
$3.08
52-Week Range:
$1.69
$3.08
Vivopower Plc Stock (VIVO) Company Profile
Compare VIVO vs FSLR, NXT, ENPH, SEDG, RUN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVO
Vivopower Plc
|
2.86 | 36.27M | 5.95M | -23.44M | -2.39M | -6.5047 |
FSLR
First Solar Inc
|
193.51 | 20.69B | 5.22B | 1.53B | 1.19B | 14.21 |
NXT
Nextpower Inc
|
130.42 | 18.54B | 3.60B | 593.09M | 585.27M | 3.9142 |
ENPH
Enphase Energy Inc
|
42.53 | 5.37B | 1.47B | 172.13M | 95.90M | 1.2908 |
SEDG
Solaredge Technologies Inc
|
51.28 | 2.88B | 1.18B | -405.45M | 80.79M | -6.8795 |
RUN
Sunrun Inc
|
13.04 | 2.99B | 2.96B | -1.01B | -2.92B | 1.7177 |
Vivopower Plc Stock (VIVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-20 | Resumed | Piper Sandler | Overweight |
| Jul-27-20 | Initiated | H.C. Wainwright | Buy |
| May-11-20 | Upgrade | William Blair | Mkt Perform → Outperform |
| May-01-19 | Upgrade | Piper Jaffray | Underweight → Neutral |
| Apr-03-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Jan-26-18 | Reiterated | Canaccord Genuity | Hold |
| Mar-28-17 | Initiated | CL King | Neutral |
| Mar-28-16 | Reiterated | Canaccord Genuity | Hold |
| Sep-10-15 | Reiterated | Canaccord Genuity | Hold |
| Jul-27-15 | Reiterated | Canaccord Genuity | Hold |
| May-04-15 | Reiterated | Canaccord Genuity | Hold |
| Nov-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-27-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-25-11 | Upgrade | Wedbush | Underperform → Neutral |
| Mar-24-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-16-10 | Initiated | Canaccord Genuity | Hold |
| Apr-07-10 | Initiated | Wedbush | Underperform |
| Nov-13-09 | Reiterated | Caris & Company | Average |
| Jul-07-09 | Initiated | Caris & Company | Average |
| Mar-06-09 | Initiated | William Blair | Mkt Perform |
View All
Vivopower Plc Stock (VIVO) Latest News
VIVO SEC FilingsVivopower International Plc 10-K, 10-Q, 8-K Forms - Stock Titan
ICE Mark Awarded to Meridian Bioscience for Alethia Molecular Assay Portfolio - Medical Product Outsourcing
Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio - Bluefield Daily Telegraph
EU’s stricter test rules: Meridian Alethia assays clear IVDR hurdle - Stock Titan
Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit - The Joplin Globe
Revenue of Meridian Bioscience Inc from 2018 to 2022 - Statista
IVD Contract Manufacturing Market Size to Reach USD 43.79 - GlobeNewswire
Cleveland biotech firm adds veteran CEO to lead board during growth phase - Crain's Cleveland Business
Shigella Test Kit Market 2026 Is Booming Worldwide by 2033 - openPR.com
Isothermal Nucleic Acid Amplification Technology Market to Worth Over US$ 17.26 Billion by 2033 | Astute Analytica - GlobeNewswire
NeoGenomics Adds Diagnostics Executive Jack Kenny To Board - Pulse 2.0
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors - BioSpace
Abilene Topic MERIDIAN BIOSCIENCE, INC. | News, Weather, Sports, Breaking News - KTXS
Rapid Medical Diagnostics Market Analysis 2025: Outlook in GCC - openPR.com
Multiplex PCR Kit Market Size to Lead at 10.64% CAGR by 2034 - GlobeNewswire
Yeast Infection Diagnostics Market Share Analysis | CAGR of 6.3% - Market.us
Breath Analyzers Market Opportunities, Key Trends, - openPR.com
United States Malaria Diagnostics Market 2025: Industry - openPR.com
2nd Ex-Magellan Exec Avoids Jail Over Faulty Lead Tests - Law360
Ex-CEO of Magellan Diagnostics avoids prison over lead-test device defect - Reuters
Bioline Launches ISOLATE II, a Precious Find for DNA and RNA Isolation - AOL.com
Shigella Test Kit Market Is Booming Worldwide 2025-2032 | Thermo - openPR.com
Feds, Ex-Magellan CEO Still Split Over Sentencing Factors - Law360
Helicobacter Pylori Non-Invasive Testing Market Size | CAGR 7.2% - Market.us
Growing Greater Cincinnati diagnostics company Meridian Bioscience names new CEO - The Business Journals
Meridian Bioscience, Inc. Announces Chief Financial Officer Changes, Effective October 14, 2025 - MarketScreener
Meridian Bioscience, Inc. Announces Executive Changes - MarketScreener
Meridian Bioscience, Inc. Promotes Andy Kitzmiller to Chief Executive Officer, Effective October 14, 2025 - MarketScreener
Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth - WV News
Biotech firm to build new manufacturing facility in suburban Cincinnati - WKRC
Meridian Bioscience to create new advanced manufacturing facility in Cincinnati suburb - The Business Journals
Meridian Bioscience Eliminates Cold Chain with the First Liquid Ambient Temperature Stable qPCR Master Mixes - Eastern Progress
Chronic Hepatitis B Virus Testing Market | Global Market Analysis Report2035 - Future Market Insights
Meridian BioscienceFinancial Details - Crunchbase
Judge Casts Doubt On Plea Deals In Blood Test Defect Case - Law360
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - globaldata.com
Rapid Tests Market to Hit USD 3.08 Billion by 2032, Driven by Rising Demand for Quick Diagnostics | SNS Insider - GlobeNewswire
Influenza Diagnostics Market Size to Hit USD 2.45 Billion - GlobeNewswire
Former Magellan Diagnostics CEO pleads guilty over lead-test device defect - Reuters
Influenza Diagnostics Market Revenue to Exceed $2.0 Bn by 2031 Amid Rising Cases and Demand for Rapid Testing – TMR Insights - PharmiWeb.com
Former Magellan exec to plead guilty to concealing lead testing device defect - Reuters
TMU to recognize outstanding honorees at 27th Bishop William A. Hughes Award Dinner April 2 - NKyTribune
Europe Hospital Acquired Infections Diagnostics Market, 2030 - Grand View Research
Chlamydia Market Report 2034: Epidemiology Data, Pipeline - openPR.com
Point of Care (POC) Diagnostics Market to Grow by USD 16.42 Billion (2024-2028) Geriatric Population Boosts Growth, Report on AI-Powered Market EvolutionTechnavio - PR Newswire
Population dynamics of sympatric Phortica spp. and first record of stable presence of Phortica oldenbergi in a Thelazia callipaeda-endemic area of Italy - Parasites & Vectors
Lead testing device company Magellan sentenced for concealing defects - Reuters
In Vitro Diagnostics Contract Manufacturing Market Report, 2030 - Grand View Research
Biosensors Market Size to Exceed USD 58.44 Billion by 2033 - BioSpace
Korean firms acquire US-based Meridian Bioscience for $1.53bn - Private Equity Insights
Judge questions 'unusual' DOJ plan to pay lead-testing device victims - Reuters
Vivopower Plc Stock (VIVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):